Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.01.25
/
50%
€9.72
Target price
13.01.26
€39.21
Performance (%)
-22.07%
Price
18.12.25
€7.57
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -22.07%. This prediction currently runs until 13.01.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -7.046% | -7.046% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $60.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€16.19
11.11.24
11.11.24
€56.29
11.11.25
11.11.25
-46.53%
12.11.25
12.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.25
13.11.23
13.11.23
€65.39
13.11.24
13.11.24
-30.31%
14.11.24
14.11.24